Immediate Ambulation and Leg Compression in the Treatment of Deep Vein Thrombosis

Similar documents
Confirmed Deep Vein Thrombosis (DVT)

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery

CLINICAL PRACTICE GUIDELINE: MOBILITY WITH A DEEP VEIN THROMBOSIS (DVT) Page 1 of 10

Venous Thromboembolic Treatment Guidelines

Joseph A. Caprini, MD, MS, FACS, RVT

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2013

ACUTE DVT MANAGEMENT Richard J. DeMasi, MD April 26, 2014

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?

Central Venous Catheters and Upper Extremity DVT: Update, Diagnosis and Management

Treatment of Venous Thromboembolism in Cancer Patients

To provide an evidenced-based approach to treatment of patients presenting with deep vein thrombosis.

Recently, a pediatric physical therapy manager. Early Ambulation After Acute Deep Vein Thrombosis: Is It Safe? Marilyn Slavin Blumenstein, MSN, RN

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

DATE: 06 May 2013 CONTEXT AND POLICY ISSUES

Paul G. Lee. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume III, A. Objective

Preventing Blood Clots in Adult Patients. Information For Patients

APSR RESPIRATORY UPDATES

Thrombosis and Hemostasis

Venous and Lymphatic Disorders

Thrombose associée au cancer. Prévention et traitement. Guy Meyer Université Paris Descartes Hopital Europeen Georges Pompidou, Paris, France

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC

Clinical Study Synopsis

Prior Authorization Guideline

6/19/2012. Update on Venous Thromboembolism Prophylaxis. Disclosure. Learning Objectives. No conflicts of interest to declare

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU

I know my value. Be an active part of your anticoagulation therapy with INR self-monitoring

Importance and Advantages of Intermittent External Pneumatic Compression Therapy in Venous Stasis Ulceration

A Guide to Healthier Legs

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults

Review. Deep-vein thrombosis (DVT) has an estimated annual incidence. Diagnosis and treatment of deep-vein thrombosis. Abstract.

DVT/PE Management with Rivaroxaban (Xarelto)

Backgrounder. Current anticoagulant therapies

Gruppo di lavoro: Malattie Tromboemboliche

Pulmonary Embolism Treatment Update

Key words: deep vein thrombosis; enoxaparin; low-molecular-weight heparin; meta-analysis; noninferiority; pulmonary embolism; unfractionated heparin

To aid practitioners in prescribing unfractionated heparin and low-molecular-weight heparins to patients.

Trust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients

ADVICE ON TRAVEL-RELATED DEEP VEIN THROMBOSIS

Outpatient strategies in the management of deep

T.E.D. Anti-Embolism Stockings

Review of Non-VKA Oral AntiCoagulants (NOACs) and their use in Great Britain

New Oral Anticoagulants. How safe are they outside the trials?

ABSTRACT The American Physical Therapy Association (APTA), in conjunction with the

Antithrombotic Therapy for VTE Disease

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM

How To Take Xarelto

0.9% Sodium Chloride injection may be used in most cases.

Guidelines for diagnosis and management of acute pulmonary embolism

Antithrombotic Therapy for VTE Disease

Clive Kearon, Susan R. Kahn, Giancarlo Agnelli, Samuel Goldhaber, Gary E. Raskob and Anthony J. Comerota. DOI /chest.

To define a diagnostic algorithm and treatment strategy for patients with acute pulmonary embolism.

Long-term treatment of deep-vein thrombosis with low-molecularweight heparin: An update of the evidence

Tired, Aching Legs? Swollen Ankles? Varicose Veins? An informative guide for patients

Information for patients who require Foam Sclerotherapy for Varicose Veins.

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY

PROFESSOR OF MEDICINE TEMPLE UNIVERSITY SCHOOL OF MEDICINE

Preventing Deep Vein Thrombosis After Stroke: Strategies and Recommendations

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

ABOUT XARELTO CLINICAL STUDIES

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Executive Summary. Motive for the request for advice

Overview of the TJC/CMS VTE Core Measures

Venous thromboembolism: reducing the risk. Quick reference guide. Issue date: January 2010

Using CDS (Clinical Decision Support) for Quality Initiatives at a Community Hospital

Evaluation of d-dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

Venous Thrombosis and Pulmonary Embolism in Children and Young Adults

Rivaroxaban A new oral anti-thrombotic Dr. Hisham Aboul-Enein Professor of Cardiology Benha University 12/1/2012

Clinically Important Pulmonary Emboli: Does Calf Vein US Alter Outcomes? 1

Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis

Peninsula Commissioning Priorities Group. Commissioning Policy Varicose Vein Referral

Deep Vein Thrombosis or Pulmonary Embolism

CDEC FINAL RECOMMENDATION

OPERATION:... Proximal tibial osteotomy Distal femoral osteotomy

Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D.

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

SCREENING COMPRESSION ULTRASOUND FOR LOWER EXTREMITY DVT

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Deep Vein Thrombosis (DVT) AUTHORS: Nancy Skinner, RN, C, CCM Peter Moran, RN, C, BSN, MS, CCM

National Patient Safety Goals Effective January 1, 2015

Prevention of Venous Thromboembolism

DVT and Pulmonary Embolism: Part II. Treatment and Prevention

Investor News. Not intended for U.S. and UK media

Deep vein thrombosis outcome and the level of oral anticoagulation therapy

National Patient Safety Goals Effective January 1, 2015

Pulmonary Embolic Disease: Caval Filtration and Other Stuff. Tony P. Smith, M.D. October 2, 2009

Pathway for the management of DVT in primary Care

National Guidance and New Protocols

Published 2011 by the American Academy of Orthopaedic Surgeons 6300 North River Road Rosemont, IL AAOS Clinical Practice Guidelines Unit

Rapid Critical Appraisal of Controlled Trials

New Oral Anticoagulants

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

The Prescribing pathway consists of a number of parts:

New Anticoagulants for the Treatment of Thromboembolism With a little subplot on superficial thrombophlebitis. Mark Crowther

National Guidance and New Protocols

Clinical Study Synopsis

University of Illinois at Chicago College of Pharmacy. Hospital Compliance with Proposed JCAHO Performance Measures for VTE

Chronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical

Transcription:

Immediate Ambulation and Leg Compression in the Treatment of Deep Vein Thrombosis Introduction Hugo Partsch, MD The introduction of subcutaneous injections of low molecular weight heparin (LMWH) instead of intravenous infusions with unfractionated heparin (UFH) allowed one to recommend home treatment of patients with deep-vein thrombosis (DVT). 1 However, the practically important question of when and how intensively these patients can ambulate is not addressed in DVT studies and meta-analyses advocating home therapy, nor in most recommendations and patients brochures. 2-4 Until recently it was also not clear if adjuvant compression therapy is of any beneficial value in the acute stage of DVT. Why Bed Rest in Acute DVT? The fear of dislodged clots causing serious or fatal pulmonary embolism (PE) has been the reason for the traditional recommendation of bed rest for some days in combination with anticoagulation. The belief that pain and swelling would be improved faster by immobilization was an additional argument favoring bed rest. Only a few studies question these dogmas. Bed Rest Does Not Prevent PE A retrospective multicenter study of 1647 patients with DVT treated conservatively by UFH and bed rest in different German hospitals reported a rate of fatal PE of 2.33%. 5 Between 1993 and 2000 we treated 1289 consecutive, mobile patients with acute DVT with LMWH, compression, and immediate ambulation in the hospital. One hundred ninetyfive patients with iliofemoral thrombosis underwent MRI that demonstrated clots in the inferior caval vein in 41 cases (21%). V/Q scans were performed at admission and repeated after 10 days. 6 PE was demonstrated in the baseline scan in 190/356 (53.4%) of iliofemoral, 355/675 (52.6%) Dis Mon 2005;51:135-140 0011-5029/2005 $30.00 0 doi:10.1016/j.disamonth.2005.03.008 DM, February/March 2005 135

of femoral, and 84/239 (35.1%) of lower leg vein thrombosis (difference iliofemoral and femoral versus lower leg DVT, P 0.001). Two-thirds of these PE had no clinical lung symptoms. In comparison to the baseline scan, new PEs occurred in 7.4, 6.4, and 3.4%, respectively, after 10 days. Only 6/77 patients with scintigraphically detected new PEs had mild pulmonary symptoms. Seventeen of the 1289 (1.32%) patients died and all underwent autopsy. Only three deaths (0.23%; 95% CI 0.048 to 0.678) were caused by PE, all patients being older than 76 years. The most frequent cause of death in the 17 patients was malignancy. Our study shows that about half of patients with proximal DVT who come in walking have pulmonary emboli detected by lung scan, but most of these emboli are asymptomatic. When these patients are treated with adequate doses of LMWH and kept walking with good compression, the life-threatening danger is over. New PEs occur very rarely, and if they do, are mostly asymptomatic. We have observed fatal PE with a frequency of 3/1289 (0.2%) in the elderly and in patients with additional severe diseases. Two randomized controlled trials have proven that there was no statistically significant difference in the frequency of new PEs compared to a baseline scan if patients with proximal DVT treated with LMWH were kept in bed or walked around with leg compression. The authors of both studies conclude that bed rest as an additional measure in the treatment of DVT is not able to substantially reduce the incidence of scintigraphically detectable pulmonary embolism and that early mobilization is safe. 7,8 A recent systematic review from Spain also demonstrates that early mobilization does not increase the rate of PE or the complication rate. 9 Bed Rest Promotes Stasis and Thrombus Propagation Bed rest promotes venous stasis and obviously has more risks concerning thrombus propagation and other complications, especially in older patients. In a retrospective analysis of phlebographic studies comparing thrombus extension in the initial stage with the result several days later, thrombus propagation was demonstrated in 26% if patients were kept at bed rest for more than 5 days, but only in 1% if mobilization was started between day 0 and 2. 10 Most of the studies in which patients with DVT had bed rest and were treated by UFH given intravenously demonstrate similar results, with thrombus progression in about 20 to 30% despite exact anticoagulation. 11 136 DM, February/March 2005

Immediate Mobilization Reduces Thrombus Growth In a randomized controlled trial in a total of 53 patients with proximal DVT, bed rest without compression was compared with walking exercises using either compression stockings or bandages. All patients were treated with LMWH and the thrombus size was assessed by Duplex examination on day 0 and day 9. A progression of thrombus length in the femoral vein was seen in 40% after bed rest and in 28% with walking and compression (NS). Taking into account the change of thrombus length, the difference between bed rest and walking with compression was statistically significant (P 0.01). 12 The influence of mobilization on thrombogenesis is not well investigated. In a recently published experiment it was demonstrated that exercise suppresses shear-induced platelet activation and subsequent polymorphonuclear leukocyte adhesion to platelets deposited at sites of vascular injury under flow and thereby reduces the risk of vascular thrombosis and inflammation. 13 Compression and Walking Reduce Pain and Swelling More than Bed Rest In the above-mentioned randomized controlled trial on 53 patients with proximal DVT, all treated by dalteparin, 200 IU/kg per body weight, 18 patients received strong Unna boot bandages; 18 patients received thigh-length compression stockings class II, and 17 patients underwent bed rest without compression. In the mobile compression groups the walking distance measured by a pedometer was between 600 and 12,000 m per day. Pain level was assessed by visual analog scale and by comparing the pain level between both legs when a blood pressure cuff producing a steadily increasing pressure to the calf was applied (modified Lowenberg test). The Lowenberg test reflects a more objective parameter for pain and allows a fair comparison between walking and bed-rest patients who would not experience pain as long as they do not walk. This test revealed a constantly elevated pain level in the bed-rest group after 3 days of initial improvement, in contrast to the walking groups with compression, who showed a continuous improvement. The completely inelastic zinc plaster bandages with a pressure on the distal lower leg of about 50 mm Hg gave better results than elastic stockings exerting a pressure of 35 mm Hg. After 9 days the pain level and the difference between the circumferences of both calves were significantly more reduced in the compression groups compared with the bed-rest group (P 0.01). Nearly all mobilized patients were free of pain and edema. There DM, February/March 2005 137

was no significant difference concerning the occurrence of new pulmonary emboli assessed by repeat V/Q scan. 12,14 Pain and swelling of the leg with symptomatic DVT have considerable subjective relevance for the patient. Up to now these clinical signs and symptoms have been widely neglected in most studies concentrating on therapeutic outcome. Immediate Mobilization and Compression May Prevent Postthrombotic Syndrome In some centers the patient with DVT is advised to stay in bed with elevated legs for the first few days to reduce pain and swelling and only then to start with mobilization. Hull and coworkers have demonstrated that an inadequate quality of initial anticoagulant response to heparin in the first 24 hours increases the recurrence rate in the next 3 months. 15 Putting a patient into bed for 24 hours will certainly also promote thrombus propagation during this time. Therefore, after diagnosis of DVT is made and LMWH is initiated, patients who were not immobilized up to this moment should be encouraged to ambulate immediately, which is tolerated very well by most patients if leg compression is strong enough. Two randomized controlled trials have compared the late outcome several years after acute, symptomatic proximal DVT in patients who wore compression stockings with those who did not. 16,17 Both studies, one performed with custom-made thigh-length stockings and one using calf-length, ready-made stockings, showed that consequent wearing of compression stockings could reduce the frequency of a postthrombotic syndrome to one-half. To date there are no convincing data available that similar effects can be achieved with long-term anticoagulation. 11 In both studies, compression therapy was started only after discharge from the hospital and not immediately after the diagnosis of DVT was made. Therefore, we have followed our patients in the above-mentioned randomized controlled trial for an average period of 2 years. Judged by the Prandoni scale, which combines five subjective symptoms with six objective signs, 18 a significantly better outcome could be found in the mobile group (median score 5.0) than in the bed-rest group (median score 8.0) (P 0.01) ( Mild PTS score 5 to 14, severe PTS score 15). 19 Mobile Patients with DVT Should Be Encouraged to Walk with Firm Compression The idea to apply firm bandages and to keep patients with deep vein thrombosis mobile was been advocated in 1910 by Heinrich Fischer, a 138 DM, February/March 2005

pupil of Unna, who recommended firm zinc plaster bandages (Unna boots) and walking exercises to treat patients with DVT. 20 It took a long time before the following recommendation in the recent ACCP Consensus document was formulated: For patients with DVT, we recommend ambulation as tolerated (Grade 1B). 21 Conclusion In general, bed rest is a potentially harmful treatment needing more careful evaluation. 22 This is also true for symptomatic, mobile outpatients with DVT, especially for those in higher age groups. At least for those patients for whom thrombolytic or surgical therapy is not indicated or feasible, we recommend starting treatment with therapeutic doses of LMWH and keeping mobile patients ambulant, encouraging them to walk as much as possible with good compression. For those therapists who are not able to apply a strong and well-fitting multilayer short-stretch bandage, good-quality compression stockings, class II to III, may be an alternative. Compression should be recommended for 2 years, depending on signs and symptoms. We need more studies in which the optimal dosage of the important antistasis measures of compression and walking should be evaluated. REFERENCES 1. Wells PS. Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism. Curr Opin Pulm Med 2001;7:360-4. 2. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7. 3. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81. 4. Schraibman IG, Milne AA, Royle EM. Home versus in-patient treatment for deep vein thrombosis (Cochrane Review). In The Cochrane Database of Systematic Reviews 2001, Issue 2. Article No.: CD003076. 5. Martin M. PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery. Clin Investig 1993;71:471-7. 6. Partsch H. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 2001;30:195-204. 7. Aschwanden M, Labs KH, Engel H, et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001;85:42-6. 8. Schellong SM, Schwarz TH, Krapp J, et al. Bed rest in deep vein thrombosis DM, February/March 2005 139

and the incidence of scintigraphic pulmonary embolism. Thromb Haemost 1999;82:127-9. 9. Trujillo-Santos AJ, Martos-Perez F, Perea-Milla E. Bed rest or early mobilization as treatment of deep vein thrombosis: a systematic review and meta-analysis. Med Clin (Barc) 2004;122:641-7. 10. Schulman S. Studies on the medical treatment of deep vein thrombosis. Acta Med Scand 1985;704(suppl):1-68. 11. Egermayer P. The effects of heparin and oral anticoagulation on thrombus propagation and prevention of the postphlebitic syndrome: a critical review of the literature. Prog Cardiovasc Dis 2001;44:69-80. 12. Blättler W, Partsch H. Leg compression and ambulation is better than bed rest for the treatment of the symptoms of acute deep venous thrombosis. Int Angiol 2003;22:393-400. 13. Wang JS, Liao CH. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface adherent platelets under shear flow in man. Thromb Haemost 2004;91:416-9. 14. Partsch H, Blättler W. Compression and walking versus bed-rest in the treatment of proximal deep venous thrombosis with low-molecular-weight heparin. J Vasc Surg 2000;32:861-9. 15. Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-14. 16. Brandjes DPM, Büller H, Hejboer H, et al. Incidence of the postthrombotic syndrome and the effects of compression stockings in patients with proximal venous thrombosis. Lancet 1997;349:759-62. 17. Prandoni P, Lensing AWA, Prins MH, et al. Below-knee elastic stockings to prevent the post-thrombotic syndrome. Ann Intern Med 2004;141:249-56. 18. Prandoni P, Lensing AW, Prins MR. Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med 1998;3:57-60. 19. Partsch H, Kaulich M, Mayer W. Immediate mobilisation in acute vein thrombosis reduces postthrombotic syndrome. Int Angiology 2004;23:206-12. 20. Fischer H. Eine neue Therapie der Phlebitis. Med Klin 1910;30:1172-80. 21. Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2004;126:401S-28S. 22. Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999;354:1229-33. 140 DM, February/March 2005